1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
Cardiovascular Needle Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, Usage, and End User Geography

Cardiovascular Needle Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, Usage, and End User Geography

  • September 2021
  • 171 pages
  • ID: 6176773
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

The cardiovascular needle market was valued at US$ 84.429 million in 2021 and is projected to reach US$ 137.855 million by 2028; it is expected to grow at a CAGR of 7.3 % from 2021 to 2028.

The growth of the cardiovascular needle market is attributed to factors such as an increase in the prevalence of cardiovascular diseases and rise in elderly population. However, the market is likely to get impacted by the preference for surgical staples over cardiovascular needles.

The cardiovascular needles are used during open-heart surgeries, cardiac valve procedures, heart transplantation procedures, coronary artery bypass graft surgeries, and so on.These needles are of two types: single use or eyeless needles and multiple use or eyed needles.

Cardiovascular needles are manufactured from new stainless-steel alloys constituting high concentrations of nickel, Surgalloy, and Ethalloy.

Cardiovascular diseases (CVDs) are the disorders of heart and blood vessels, and the category includes cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions.Tobacco consumption, unhealthy diet, and physical inactivity, which increase the risk of heart attacks and strokes, are a few of the major lifestyle factors that lead to the CVDs.

Other risk factors causing these diseases include hypertension, diabetes, and increased cholesterol levels.CVDs are among the top 10 causes of death across the world.

According to the World Health Organization (WHO), cardiovascular diseases are number one cause of the death across the world.Cardiovascular diseases (CVDs) are likely to remain the largest cause of morbidity and mortality across the world.

As per WHO data, ~17.9 million people in the world died from CVDs in 2016, which was 31.0% of the total mortality reported in that year. Among these, ~85% death cases were due to heart attack and stroke. Fat depositions around blood vessels that prevents blood from flowing to the heart or brain is a main cause of heart attack and stroke. Bleeding vessels or blood clots in brain are a few other causes of stroke.

According to the European Cardiovascular Disease Statistics 2017, CVDs cause 3.9 million and more than 1.8 million death cases in Europe and European Union (EU), respectively, every year. Thus, these diseases account for 45.0% and 37.0% of total mortality in Europe and the EU, respectively. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the US, i.e., ~50% of the US adult population, suffer from CVDs every year. According to the Journal of the American College of Cardiology, Asia has increasingly high prevalence of high blood pressure, diabetes, elevated cholesterol levels. Countries such as Japan, China, and India are the major contributors to the total CVD incidence in the region.
Thus, the significantly rising incidence of CVDs across the world is contributing to the high demand for diagnostic and treatment cardiovascular devices, which is driving the cardiovascular needles market growth.

The COVID-19 pandemic has become the most significant challenge across the world.As this pandemic has stressed healthcare systems across the globe, prioritizing the limited resources was essential to minimize hospital admissions.

Cardiac surgical patients not only require vital ICU resources but are also potentially in the highest risk category of complications of COVID-19.Hence, most of the hospitals and surgical enters has considered to cancel or postponed elective surgeries including cardiovascular surgeries.

Hence impact of COVID 19 is expected to be somewhat negative on cardiovascular needle market in short run. However, in long run, as the vaccination schedule will establishes and transmission rate decreases, healthcare systems will return to normal and will have increased demand for cardiovascular needle, which will support the market.

Based on type, the cardiovascular needle market is segmented into round-bodied needles and cutting needles. The round-bodied needles segment would account for a larger market share in 2021, and the cutting needles segment is anticipated to register a higher CAGR in the market during the forecast period.

Based on application, the cardiovascular needle market is segmented into open heart surgery and cardiac valve procedures.The open-heart surgery segment is expected to hold a larger share of the market in 2021, and it is estimated to register a higher CAGR in the market during 2021-2028.

Growth of the open-heart surgery segment is attributed to the increasing open-heart surgeries across the globe.

Based on usage, the cardiovascular needle market is segmented into single use and multiple use.The single use segment is estimated to account for a larger market share in 2021.

The market for this segment is estimated to grow at a higher CAGR from 2021 to 2028.

Based on end user, the cardiovascular needle market is segmented into hospitals and clinics, ambulatory surgical centers, and cardiovascular centers. The hospitals and clinics segment would hold the largest share of the market in 2021; it is further estimated to register the highest CAGR in the market during the forecast period.

American Heart Association, European Cardiovascular Disease Statistics, the Journal of the American College of Cardiology, National Health Service, the Food and Drug Administration, the World Health Organization, the Centers for Disease Control and Prevention, and the registry of cardiovascular diseases of various countries are among the major primary and secondary sources referred to while preparing this report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on